Abstract:
A disease treatment is provided by controlling the expression of a protein induced by a heat shock factor. The novel compound benzo-1,3-dioxole provides an inhibitor of HSF activity or an inhibitor of inducing the production of a protein regulated by HSF, which inhibits the activity of a heat shock factor, a transcriptional regulatory factor, thereby in turn inhibiting transcription of a structural gene having a heat shock element sequence in the gene region for transcriptional regulation into RNA, and thus inhibiting translation of the gene into a protein, and resulting in inhibition of inducing production of RNA or protein encoded by the gene. It also provides a drug for treating or preventing cancer through thermotherapy and a drug for treating or preventing stress diseases such as depression.
Abstract:
Un DNA del punto (a) o (b) siguiente: (a) un DNA que comprende la secuencia de bases mostrada en la SEQ ID NO: 1, (b) un DNA que se hibrida con un DNA que consiste en una secuencia de bases complementaria de la secuencia de bases mostrada en la SEQ ID NO: 1 bajo condiciones rigurosas, y que codifica un polipéptido que tiene una actividad para reducir asimétricamente (3S)-1-cloro-3-terc-butoxicarbonilamino-4-fenil-2-butanona, representada por la fórmula (1) siguiente: ** ver fórmula** para producir (2R,3S)-1-cloro-3-terc-butoxicarbonilamino-4-fenil-2-butanol, representado por la fórmula (2) siguiente:** ver fórmula**
Abstract:
The present invention relates to a polypeptide having an activity to asymmetrically reduce (3S)-1-chloro-3-tert-butoxycarbonylamino-4-phenyl-2-butanone to produce (2R,3S)-1-chloro-3-tert-butoxycarbonylamino-4-phenyl-2-butanol isolated from a microorganism belonging to the genus Ogataea, a DNA encoding the polypeptide and a transformant that produces the polypeptide. The present invention moreover relates to a method of producing (2R,3S)-1-chloro-3-tert-butoxycarbonylamino-4-phenyl-2-butanol utilizing the polypeptide or the transformant. Using the polypeptide or transformant of the present invention, optically active alcohols such as (2R,3S)-1-chloro-3-tert-butoxycarbonylamino-4-phenyl-2-butanol and the like can be produced efficiently.
Abstract:
A pharmaceutical composition having excellent peroral absorbability and comprising coenzyme Q10 as the active ingredient. In this composition, the coenzyme Q10 comprises more than 20 % by weight of reduced coenzyme Q10.
Abstract:
A disease treatment is provided by controlling the expression of a protein induced by a heat shock factor. The novel compound benzo-1,3-dioxole provides an inhibitor of HSF activity or an inhibitor of inducing the production of a protein regulated by HSF, which inhibits the activity of a heat shock factor, a transcriptional regulatory factor, thereby in turn inhibiting transcription of a structural gene having a heat shock element sequence in the gene region for transcriptional regulation into RNA, and thus inhibiting translation of the gene into a protein, and resulting in inhibition of inducing production of RNA or protein encoded by the gene. It also provides a drug for treating or preventing cancer through thermotherapy and a drug for treating or preventing stress diseases such as depression.
Abstract:
Excellent decarbamylase variants which are more advantageously usable industrially are provided by clarifying the stereostructure of decarbamylase by X-ray crystalline structure analysis and designing molecules aiming at elevating the reactivity to the substrates (D-N-carbamoyl- alpha -amino acids), etc. by using the stereostructure. More particularly speaking, provision is made of: the stereostructure of decarbamylase determined by X-ray crystalline structure analysis, stereostructure models of variants thereof and stereostructure models of complexes thereof with substrates, products, etc.; a molecular design method with the use of these stereostructures; a method of obtaining decarbamylase variants by using this method; the decarbamylase variants obtained by this method; and a method of designing and producing variants of proteins which are similar to decarbamylase in structure.